Forest Laboratories LLC v. Teva Pharmaceuticals USA Inc.

COMPLAINT filed against Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1698415.) - filed by Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd.. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(mas, ) (Entered: 03/30/2015)

2015-03-27

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mas, ) (Entered: 03/30/2015)

2015-03-27

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/26/15. Date of Expiration of Patent: 6/5/22.Thirty Month Stay Deadline: 7/21/2018. (mas, ) (Entered: 03/30/2015)

2015-03-27

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,834,020; 8,193,195; 8,236,804; 8,673,921;. (mas, ) (Entered: 03/30/2015)

2015-03-27

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate FL Holding CV, Other Affiliate FLI International LLC, Other Affiliate Actavis PLC for Forest Laboratories Holdings Ltd.; Other Affiliate FLI International LLC, Other Affiliate Tango US Holdings Inc. for Forest Laboratories LLC filed by Forest Laboratories Holdings Ltd., Forest Laboratories LLC. (mas, ) (Entered: 03/30/2015)

2015-03-27

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck Verwaltungs GmbH for Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung filed by Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (mas, ) (Entered: 03/30/2015)

2015-03-27

1

View

Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA Inc. on 3/30/2015. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mas, )

2015-03-30

1

No Actions

SUMMONS Returned Executed by Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd.. Teva Pharmaceuticals USA Inc. served on 3/31/2015, answer due 4/21/2015. (Blumenfeld, Jack) (Entered: 04/01/2015)

2015-04-01

1

View

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 4/1/2015. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(asw) (Entered: 04/01/2015)

2015-04-01

1

View

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:15-cv-00272-UNA, 1:15-cv-00273-UNA, 1:15-cv-00274-UNA, 1:15-cv-00275-UNA, 1:15-cv-00277-UNA(bkb)

2015-04-01

1

No Actions

STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to May 21, 2015 - filed by Teva Pharmaceuticals USA Inc.. (Palapura, Bindu) (Entered: 04/20/2015)

2015-04-20

1

View

SO ORDERED - re 9 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to May 21, 2015 filed by Teva Pharmaceuticals USA Inc., Set/Reset Answer Deadlines: Teva Pharmaceuticals USA Inc. answer due 5/21/2015. Ordered by Judge Gregory M. Sleet on 4/22/2015. (mdb)

2015-04-22

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2015-04-22

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, David A. Manspeizer, Vinita Ferrera, Emily R. Whelan, Andrej Barbic, Anna Lumelsky, Shira C. Hoffman - filed by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Noreika, Maryellen) (Entered: 04/29/2015)

2015-04-29

1

View

SO ORDERED - re 10 MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, David A. Manspeizer, Vinita Ferrera, Emily R. Whelan, Andrej Barbic, Anna Lumelsky, Shira C. Hoffman filed by Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd., Merck KGaA. Ordered by Judge Gregory M. Sleet on 4/29/2015. (mdb)

2015-04-29

1

No Actions

SO ORDERED

2015-04-29

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, David A. Manspeizer, Vinita Ferrera, Emily R. Whelan, Andrej Barbic, Ph.D., Anna Lumelsky, and Shira C. Hoffman (CORRECTED) - filed by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Noreika, Maryellen) (Entered: 05/01/2015)

2015-05-01

1

View

SO ORDERED - re (14 in 1:15-cv-00277-GMS) MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, David A. Manspeizer, Vinita Ferrera, Emily R. Whelan, Andrej Barbic, Ph.D., Anna Lumelsky, and Shira C. Hoffman filed by Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd., Merck KGaA, (11 in 1:15-cv-00275-GMS) MOTION for Pro Hac Vice Appearance of Attorney David B. Bassett, David A. Manspeizer, Vinita Ferrera, Emily R. Whelan, Andrej Barbic, Ph.D., Anna Lumelsky, and Shira C. Hoffman (CORRECTED) filed by Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd., Merck KGaA. Ordered by Judge Gregory M. Sleet on 5/4/2015. Associated Cases: 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

2015-05-04

1

No Actions

SO ORDERED

2015-05-04

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney John C. Rozendaal, Michael E. Joffre, and Miles J. Sweet of Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C. - filed by Teva Pharmaceuticals USA Inc.. (Moore, David) (Entered: 05/18/2015)

2015-05-18

1

View

SO ORDERED - re 12 MOTION for Pro Hac Vice Appearance of Attorney John C. Rozendaal, Michael E. Joffre, and Miles J. Sweet of Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C. filed by Teva Pharmaceuticals USA Inc. Ordered by Judge Gregory M. Sleet on 5/19/2015. (mdb)

2015-05-19

1

No Actions

Pro Hac Vice Attorney Michael E. Joffre,John C. Rozendaal,Miles J. Sweet for Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2015-05-19

1

No Actions

SO ORDERED

2015-05-19

1

No Actions

Add Attorneys - PHV only

2015-05-19

1

No Actions

ANSWER to 1 Complaint,, COUNTERCLAIM against Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung by Teva Pharmaceuticals USA Inc..(Moore, David) (Entered: 05/21/2015)

2015-05-21

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA Inc. filed by Teva Pharmaceuticals USA Inc.. (Moore, David) (Entered: 05/21/2015)

2015-05-21

1

View

ANSWER to 13 Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung.(Noreika, Maryellen) (Entered: 06/15/2015)

2015-06-15

1

View

STIPULATION TO EXTEND TIME for parties to submit Joint Status Report and proposed scheduling order to July 9, 2015 - filed by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Blumenfeld, Jack) (Entered: 06/19/2015)

2015-06-19

1

View

SO ORDERED

2015-06-22

1

No Actions

SO ORDERED, re (16 in 1:15-cv-00275-GMS, 16 in 1:15-cv-00274-GMS, 16 in 1:15-cv-00277-GMS, 18 in 1:15-cv-00273-GMS, 14 in 1:15-cv-00272-GMS) STIPULATION TO EXTEND TIME for parties to submit Joint Status Report and proposed scheduling order to July 9, 2015 filed by Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd., Merck KGaA. Set/Reset deadlines: Joint Status Report and proposed scheduling order due by July 9, 2015. Ordered by Judge Gregory M. Sleet on 6/22/2015. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(asw)

2015-06-22

1

No Actions

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Tango U.S. Holdings Inc., Other Affiliate Allergan plc for Forest Laboratories LLC, Forest Laboratories LLC, Forest Laboratories LLC, Forest Laboratories LLC, Forest Laboratories LLC filed by Forest Laboratories LLC. (Blumenfeld, Jack) (Entered: 07/02/2015)

2015-07-02

1

View

Joint STATUS REPORT by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Blumenfeld, Jack) (Entered: 07/10/2015)

2015-07-10

1

View

- CORRECTING ENTRY

2015-07-10

1

No Actions

CORRECTING ENTRY: The Joint Status Reports have been removed from the docket. The plaintiffs shall refile the corrected versions. Associated Cases: 1:15-cv-00277-GMS, 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS(mdb)

2015-07-10

1

No Actions

Oral Order

2015-07-22

1

No Actions

ORAL ORDER SCHEDULING A STATUS TELECONFERENCE: A Teleconference, to discuss the Joint Status Report and how these matters will proceed, has been set for Friday, July 31, 2015, at 10:00 AM with the Honorable Gregory M. Sleet. Counsel for plaintiff is directed to arrange the conference call. The parties shall contact chambers at (302) 573-4559 once all the participants are on the line. Ordered by Judge Gregory M. Sleet on 7/22/2015. (ctd)

2015-07-22

1

No Actions

Oral Order

2015-07-31

1

No Actions

Telephone Conference

2015-07-31

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Status/Scheduling Conference held on 7/31/2015. Discussion on the consolidation proposals and the disagreements found in the footnotes on page 22 of the JSR (DI 17 ). The cases will be consolidated up to and including the pretrial conference, where the Court will decide if the cases will be tried separately or together. For now, the Court will set aside 10 days for a consolidated bench trial. The parties are permitted to file letter briefs for permission to file summary judgment motions. An oral order regarding the schedule will be entered shortly. (Court Reporter Kevin Maurer.) Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

2015-07-31

1

No Actions

ORAL ORDER - Pursuant to the teleconference on July 31, 2015, the Court will adopt the proposed schedule with the following additions: A Markman Hearing (4 hours) is set for 10/19/2016 at 9:30 AM in Courtroom 4A; Letter Briefing re Summary Judgment: Opening Letters due by 10/23/2017, Answering Letters due by 11/1/2017, Reply Letters due by 11/6/2017; The Final Proposed Pretrial Order is due by 12/6/2017; The Final Pretrial Conference is set for 12/18/2017 at 10:00 AM via teleconference; A consolidated 10-day Bench Trial is set for 1/8/2018 at 9:00 AM in Courtroom 4A. The issue of separate trials will be discussed during the Pretrial Conference. Cases are referred to the Magistrate Judge for exploring ADR. Plaintiffs shall file a proposed scheduling order that incorporates this order by 8/10/2015. Ordered by Judge Gregory M. Sleet on 7/31/2015. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

2015-07-31

1

No Actions

PROPOSED ORDER -- Scheduling Order -- by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Attachments: # 1 Letter to The Honorable Gregory M. Sleet from M. Noreika enclosing scheduling order)(Noreika, Maryellen) (Entered: 08/10/2015)

2015-08-10

1

View

Official Transcript of T/C held on 07 31 15 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/10/2015. Redacted Transcript Deadline set for 9/21/2015. Release of Transcript Restriction set for 11/18/2015. (kjm) (Entered: 08/20/2015)

2015-08-20

1

View

- CORRECTING ENTRY

2015-08-21

1

No Actions

CORRECTING ENTRY: The Proposed Scheduling Order has been replaced to correct the language under the Settlement Conference section. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

2015-08-21

1

No Actions

Remark

2015-08-24

1

No Actions

SO ORDERED AND Scheduling Order - Patent

2015-08-24

1

No Actions

SCHEDULING ORDER - re (19 in 1:15-cv-00275-GMS, 20 in 1:15-cv-00277-GMS, 21 in 1:15-cv-00274-GMS, 23 in 1:15-cv-00273-GMS, 18 in 1:15-cv-00272-GMS) Proposed Scheduling Order: CASES ARE CONSOLIDATED FOR ALL PURPOSES. ALL FUTURE FILINGS SHALL BE MADE ONLY IN LEAD C.A. NO. 15-272-GMS. Case is referred to the Magistrate Judge for the purpose of exploring ADR. Motions to Join Parties and Amend Pleadings due by 10/5/2016., Claim Construction Opening Brief due by 6/15/2016., Claim Construction Answering Brief due by 7/20/2016., A Markman Hearing is set for 10/19/2016 at 09:30 AM in Courtroom 4A., Fact Discovery completed by 2/17/2017., Opening Expert Reports due by 4/21/2017., Rebuttal Expert Reports due by 6/20/2017., Expert Discovery due by 10/11/2017., Letter Briefing re Summary Judgment: Opening Letters due by 10/23/2017, Answering Letters due by 11/1/2017, Reply Letters due by 11/6/2017., Final Pretrial Order due by 12/6/2017., A Final Pretrial Conference is set for 12/18/2017 at 10:00 AM via telephone., A 10-day Bench Trial is set for 1/8/2018 at 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet.). Ordered by Judge Gregory M. Sleet on 8/24/2015. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

2015-08-24

1

No Actions

Remark - Cases have been consolidated for all purposes. ALL FUTURE FILINGS SHALL BE MADE ONLY IN LEAD C.A. NO. 15-272-GMS. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

2015-08-24

1

No Actions

Case Referred to Mediation - Magistrate Judge only

2015-09-01

1

No Actions

CASE REFERRED to Judge Thynge for Mediation. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(cak)

2015-09-01

1

No Actions

ORDER: On or before September 16, 2015, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in this Order. Signed by Judge Mary Pat Thynge on 9/2/15. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(cak) (Entered: 09/02/2015)

2015-09-02

1

View

- CORRECTING ENTRY

2015-12-21

1

No Actions

CORRECTING ENTRY: The Notice of Service (formerly DI 22) has been removed from the docket per request from counsel. (mdb)

2015-12-21

1

No Actions

STIPULATION of Dismissal as to Teva Pharmaceuticals USA, Inc. Only by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Noreika, Maryellen) Modified on 7/11/2017 (mdb). (Entered: 06/30/2017)

2017-06-30

1

View

SO ORDERED - re (151 in 1:15-cv-00272-GMS, 22 in 1:15-cv-00275-GMS) Stipulation of Dismissal as to Teva Pharmaceuticals USA, Inc. Only. Signed by Judge Gregory M. Sleet on 7/12/2017. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00275-GMS(mdb) (Entered: 07/12/2017)

2017-07-12

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of dismissal)(mdb) (Entered: 07/12/2017)

2017-07-12

1

View

Terminate Case - Civil

2017-07-12

1

No Actions

CASE CLOSED (mdb)

2017-07-12

1

No Actions

Overview

Parties

Defendant

Teva Pharmaceuticals USA Inc. Follow

Represented By

Plaintiff

Merck Patent Gesellschaft mit beschrankter Haftung Follow

Represented By

Merck KGaA Follow

Represented By

Forest Laboratories Holdings Ltd. Follow

Represented By

Forest Laboratories LLC Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mas, ) (Entered: 03/30/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/26/15. Date of Expiration of Patent: 6/5/22.Thirty Month Stay Deadline: 7/21/2018. (mas, ) (Entered: 03/30/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,834,020; 8,193,195; 8,236,804; 8,673,921;. (mas, ) (Entered: 03/30/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck Verwaltungs GmbH for Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung filed by Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (mas, ) (Entered: 03/30/2015)

Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceuticals USA Inc. on 3/30/2015. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (mas, )

SUMMONS Returned Executed by Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung, Forest Laboratories LLC, Forest Laboratories Holdings Ltd.. Teva Pharmaceuticals USA Inc. served on 3/31/2015, answer due 4/21/2015. (Blumenfeld, Jack) (Entered: 04/01/2015)

ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 4/1/2015. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(asw) (Entered: 04/01/2015)

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:15-cv-00272-UNA, 1:15-cv-00273-UNA, 1:15-cv-00274-UNA, 1:15-cv-00275-UNA, 1:15-cv-00277-UNA(bkb)

STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to May 21, 2015 - filed by Teva Pharmaceuticals USA Inc.. (Palapura, Bindu) (Entered: 04/20/2015)

SO ORDERED - re 9 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the Complaint to May 21, 2015 filed by Teva Pharmaceuticals USA Inc., Set/Reset Answer Deadlines: Teva Pharmaceuticals USA Inc. answer due 5/21/2015. Ordered by Judge Gregory M. Sleet on 4/22/2015. (mdb)

~Util - Set/Reset Answer Deadline AND SO ORDERED

SO ORDERED

SO ORDERED

MOTION for Pro Hac Vice Appearance of Attorney John C. Rozendaal, Michael E. Joffre, and Miles J. Sweet of Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C. - filed by Teva Pharmaceuticals USA Inc.. (Moore, David) (Entered: 05/18/2015)

SO ORDERED - re 12 MOTION for Pro Hac Vice Appearance of Attorney John C. Rozendaal, Michael E. Joffre, and Miles J. Sweet of Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C. filed by Teva Pharmaceuticals USA Inc. Ordered by Judge Gregory M. Sleet on 5/19/2015. (mdb)

Pro Hac Vice Attorney Michael E. Joffre,John C. Rozendaal,Miles J. Sweet for Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

SO ORDERED

Add Attorneys - PHV only

ANSWER to 1 Complaint,, COUNTERCLAIM against Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung by Teva Pharmaceuticals USA Inc..(Moore, David) (Entered: 05/21/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries Ltd. for Teva Pharmaceuticals USA Inc. filed by Teva Pharmaceuticals USA Inc.. (Moore, David) (Entered: 05/21/2015)

ANSWER to 13 Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung.(Noreika, Maryellen) (Entered: 06/15/2015)

STIPULATION TO EXTEND TIME for parties to submit Joint Status Report and proposed scheduling order to July 9, 2015 - filed by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Blumenfeld, Jack) (Entered: 06/19/2015)

SO ORDERED

Joint STATUS REPORT by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Blumenfeld, Jack) (Entered: 07/10/2015)

- CORRECTING ENTRY

CORRECTING ENTRY: The Joint Status Reports have been removed from the docket. The plaintiffs shall refile the corrected versions. Associated Cases: 1:15-cv-00277-GMS, 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS(mdb)

Oral Order

Oral Order

Telephone Conference

- CORRECTING ENTRY

CORRECTING ENTRY: The Proposed Scheduling Order has been replaced to correct the language under the Settlement Conference section. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

Remark

SO ORDERED AND Scheduling Order - Patent

Remark - Cases have been consolidated for all purposes. ALL FUTURE FILINGS SHALL BE MADE ONLY IN LEAD C.A. NO. 15-272-GMS. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(mdb)

Case Referred to Mediation - Magistrate Judge only

CASE REFERRED to Judge Thynge for Mediation. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00273-GMS, 1:15-cv-00274-GMS, 1:15-cv-00275-GMS, 1:15-cv-00277-GMS(cak)

- CORRECTING ENTRY

CORRECTING ENTRY: The Notice of Service (formerly DI 22) has been removed from the docket per request from counsel. (mdb)

STIPULATION of Dismissal as to Teva Pharmaceuticals USA, Inc. Only by Forest Laboratories Holdings Ltd., Forest Laboratories LLC, Merck KGaA, Merck Patent Gesellschaft mit beschrankter Haftung. (Noreika, Maryellen) Modified on 7/11/2017 (mdb). (Entered: 06/30/2017)

SO ORDERED - re (151 in 1:15-cv-00272-GMS, 22 in 1:15-cv-00275-GMS) Stipulation of Dismissal as to Teva Pharmaceuticals USA, Inc. Only. Signed by Judge Gregory M. Sleet on 7/12/2017. Associated Cases: 1:15-cv-00272-GMS, 1:15-cv-00275-GMS(mdb) (Entered: 07/12/2017)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of dismissal)(mdb) (Entered: 07/12/2017)

Terminate Case - Civil

CASE CLOSED (mdb)

Track Case Updates

Teva Pharmaceuticals USA Inc.

Merck Patent Gesellschaft mit beschrankter Haftung

Merck KGaA

Forest Laboratories Holdings Ltd.

Forest Laboratories LLC